Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel project report No. 2

Ophthalmic Epidemiology

Volumn 17, Issue 1, 2010, Pages 66-73

  Clemons, Traci E ^a   Gillies, Marc C ^b   Chew, Emily Y ^c   Bird, Alan C ^d   Peto, Tunde ^d   Figueroa, Maria J ^a,e   Harrington, Molly W ^a,e  

^a EMMES CORPORATION   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NATIONAL EYE INSTITUTE   (United States)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

^e Macular Telangiectasia Research Group

Author keywords

Idiopathic; Macular; Natural history; Telangiectasia; Visual acuity

Indexed keywords

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HISTORY OF MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; TELANGIECTASIA; VISUAL ACUITY; CLASSIFICATION; HEALTH STATUS; MIDDLE AGED; PATHOLOGY; PHOTOGRAPHY; PHYSIOLOGY; RETINA BLOOD VESSEL; RETINA DISEASE; TIME;

AGED; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PHOTOGRAPHY; RETINAL DISEASES; RETINAL VESSELS; RISK FACTORS; TELANGIECTASIS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 75749134152     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286580903450361     Document Type: Article

References (17)

1. Gass JDM. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. V. Retinal telangiectasis. Arch Ophthalmol 1968;80:592-605.
2. Gass JD, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 1982;100:769-780.
3. Gass JDM, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology 1993;1536-1546.
4. Gass JDM. Stereoscopic atlas of macular disease: diagnosis and treatment. St. Louis: Mosby, 1987.
5. Yannuzi JA, Bardal AMC, Freund KB, et al. Idiopathic macular telangiectasia. Arch Ophthalmol 2006;124:450-460.
6. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7. Ophthalmol 1991;98:741-756.
7. Ferris FL, Kassoff A, Bresnick GH, et al. New visual acuity charts for clinical research. Am J Ophthalmol 1982;94: 91-96.
8. Liang, KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
9. Helb HM, Charbel Issa P, Berendschot TT, et al. Abnormal macular pigment distribution in type 2 macular telangiectasia. Retina 2008;28:808-816.
10. Wong WT, Forooghian F, Majumdar Z, et al. Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. Am J Ophthalmol 2009 Jun 30. [Epub ahead of print] PMID: 19573860.
11. Clemons TE, Gillies MC, Chew EY, et al. The National Eye Institute visual function questionnaire in the macular telangiectasia (MacTel) project: MacTel project report no. 1. IOVS. 2008;49(10):4340-4346.
12. Eliassi-Rad B, Green WR. Histologic study of presumed parafoveal telangiectasis. Retina 1999;9:332-335.
13. Green, WR, Quigley, HA, de la Cruz, Z, et al. Parafoveal retinal telangiectasis: light and electron microscopy studies, Trans Ophthalmol Soc UK 1980;100:162-170.
14. Millay, RH, Klein, ML, Handelman, IL, et al. Abnormal glucose metabolism and parafoveal telangiectasia, Am J Ophthalmol 1986;102:363-370.
15. Chew, EY, Murphy, RP, Newsome, DA, et al. Parafoveal telangiectasis and diabetic retinopathy, Arch Ophthalmol 1986;104:71-75.
16. Barbazetto IA, Room M, Yannuzzi NA, et al. ATM gene variants in patients with idiopathic perifoveal telangiectasia. Invest Ophthalmol Vis Sci 2008;49:3806-3811.
17. Gillies MC, Zhu M, Chew E, et al. Familial Asymptomatic Macular Telangiectasia Type 2. Ophthalmology. In press.